Literature DB >> 2516841

Presence of aberrant transcripts of ret proto-oncogene in a human papillary thyroid carcinoma cell line.

Y Ishizaka1, F Itoh, T Tahira, I Ikeda, T Ogura, T Sugimura, M Nagao.   

Abstract

In a papillary thyroid carcinoma cell line, TPC-1, we found transcripts hybridizing to ret proto-oncogene (proto-ret) cDNA probes. The transcripts hybridized to the probes encoding the kinase domain but not to those of the transmembrane and extracellular domains of proto-ret. The sizes of the main transcripts in TPC-1 were aberrant, being 2.0, 2.5, 4.0 and 5.0 kb. In the neuroblastoma cell lines, the transcripts were 3.9, 4.5, 6.0 and 7.0 kb, which have been proved to be generated by alternative splicing and polyadenylation from the non-altered proto-ret oncogene. All of the four transcripts in TPC-1 are about 2 kb smaller than the corresponding ones in the neuroblastoma. From the length of the transcripts, it is suspected that the transcripts in TPC-1 are a rearranged form of proto-ret. This is the first report describing the aberrant transcripts of proto-ret in a human tumor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2516841      PMCID: PMC5917935          DOI: 10.1111/j.1349-7006.1989.tb01645.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  14 in total

1.  Establishment and biological characterization of an in vitro human cytomegalovirus latency model.

Authors:  J Tanaka; T Ogura; H Sato; M Hatano
Journal:  Virology       Date:  1987-11       Impact factor: 3.616

2.  ret transforming gene encodes a fusion protein homologous to tyrosine kinases.

Authors:  M Takahashi; G M Cooper
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

3.  Activation of a novel human transforming gene, ret, by DNA rearrangement.

Authors:  M Takahashi; J Ritz; G M Cooper
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

4.  Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.

Authors:  M Takahashi; Y Buma; T Iwamoto; Y Inaguma; H Ikeda; H Hiai
Journal:  Oncogene       Date:  1988-11       Impact factor: 9.867

5.  Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing.

Authors:  Y Ishizaka; M Ochiai; T Tahira; T Sugimura; M Nagao
Journal:  Oncogene       Date:  1989-06       Impact factor: 9.867

6.  Expression of proto-ret mRNA in embryonic and adult rat tissues.

Authors:  T Tahira; Y Ishizaka; T Sugimura; M Nagao
Journal:  Biochem Biophys Res Commun       Date:  1988-06-30       Impact factor: 3.575

7.  Molecular cloning and characterization of human ret-II oncogene.

Authors:  Y Ishizaka; T Tahira; M Ochiai; I Ikeda; T Sugimura; M Nagao
Journal:  Oncogene Res       Date:  1988-09

8.  Primitive neuroectodermal tumor (neuroepithelioma) of spinal nerve root -- Report of an adult case and establishment of a cell line.

Authors:  S Ishikawa; Y Ohshima; T Suzuki; S Oboshi
Journal:  Acta Pathol Jpn       Date:  1979-03

9.  Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage.

Authors:  N E Simpson; K K Kidd; P J Goodfellow; H McDermid; S Myers; J R Kidd; C E Jackson; A M Duncan; L A Farrer; K Brasch
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

10.  A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases.

Authors:  A Fusco; M Grieco; M Santoro; M T Berlingieri; S Pilotti; M A Pierotti; G Della Porta; G Vecchio
Journal:  Nature       Date:  1987 Jul 9-15       Impact factor: 49.962

View more
  17 in total

1.  Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

Authors:  M Santoro; F Carlomagno; I D Hay; M A Herrmann; M Grieco; R Melillo; M A Pierotti; I Bongarzone; G Della Porta; N Berger
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

2.  Differential effects of cetuximab and AEE 788 on epidermal growth factor receptor (EGF-R) and vascular endothelial growth factor receptor (VEGF-R) in thyroid cancer cell lines.

Authors:  S Hoffmann; A Burchert; A Wunderlich; Y Wang; S Lingelbach; L C Hofbauer; M Rothmund; A Zielke
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

Review 3.  Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer.

Authors:  Tania Pilli; Kanteti V Prasad; Shankar Jayarama; Furio Pacini; Bellur S Prabhakar
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

4.  Chromosomal rearrangements in post-Chernobyl papillary thyroid carcinomas: evaluation by spectral karyotyping and automated interphase FISH.

Authors:  Ludwig Hieber; Reinhard Huber; Verena Bauer; Quirin Schäffner; Herbert Braselmann; Geraldine Thomas; Tatjana Bogdanova; Horst Zitzelsberger
Journal:  J Biomed Biotechnol       Date:  2011-03-13

5.  Synthesis and evaluation of 99mTc-labelled monoclonal antibody 1D09C3 for molecular imaging of major histocompatibility complex class II protein expression.

Authors:  Gaurav Malviya; E F J de Vries; Rudi A Dierckx; Alberto Signore
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

6.  Delineating chromosomal breakpoints in radiation-induced papillary thyroid cancer.

Authors:  Heinz-Ulrich G Weier; Yuko Ito; Johnson Kwan; Jan Smida; Jingly F Weier; Ludwig Hieber; Chun-Mei Lu; Lars Lehmann; Mei Wang; Haig J Kassabian; Hui Zeng; Benjamin O'Brien
Journal:  Genes (Basel)       Date:  2011-09-01       Impact factor: 4.096

7.  Expression of ret proto-oncogene in human neuroblastomas.

Authors:  M Nagao; Y Ishizaka; A Nakagawara; K Kohno; M Kuwano; T Tahira; F Itoh; I Ikeda; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1990-04

8.  An epistatic interaction between the PAX8 and STK17B genes in papillary thyroid cancer susceptibility.

Authors:  Iñigo Landa; Cesar Boullosa; Lucía Inglada-Pérez; Ana Sastre-Perona; Susana Pastor; Antonia Velázquez; Veronika Mancikova; Sergio Ruiz-Llorente; Francesca Schiavi; Ricard Marcos; Nuria Malats; Giuseppe Opocher; Ramon Diaz-Uriarte; Pilar Santisteban; Alfonso Valencia; Mercedes Robledo
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

9.  Aberrantly methylated genes in human papillary thyroid cancer and their association with BRAF/RAS mutation.

Authors:  Yasuko Kikuchi; Eiichi Tsuji; Koichi Yagi; Keisuke Matsusaka; Shingo Tsuji; Junichi Kurebayashi; Toshihisa Ogawa; Hiroyuki Aburatani; Atsushi Kaneda
Journal:  Front Genet       Date:  2013-12-05       Impact factor: 4.599

10.  Multi-Color Spectral Transcript Analysis (SPECTRA) for Phenotypic Characterization of Tumor Cells.

Authors:  Joanne H Hsu; Jingly F Weier; Heinz-Ulrich G Weier; Yuko Ito
Journal:  Biomolecules       Date:  2013-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.